Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study

Jane N. Winter, MD, Fangxin Hong, PhD, Lisa M. Rimsza, MD, Michael LeBlanc, Ph.D., Daina Variakojis, M.D., Maryla Krajewska, M.D., Thomas M. Habermann, MD, Ari Melnick, MD, James K. Weick, MD, Frederick Pollock, Ihab Botros, Ph.D., John C. Reed, MD, PhD, Richard I Fisher, MD, Brad S. Kahl, MD, Sandra J. Horning, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 87.

https://doi.org/10.1182/blood.V118.21.87.87

Published: 2011

Journal Articles

Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer

Juan M. Zapata, David Llobet, Maryla Krajewska, Sophie Lefebvre, Christina L. Kress, John C. Reed

Blood (2009) 113 (19): 4595–4603.

https://doi.org/10.1182/blood-2008-07-165456

Published: 2009

Includes: Supplemental data

Journal Articles

Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2–transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)

Shinichi Kitada, Christina L. Kress, Maryla Krajewska, Lee Jia, Maurizio Pellecchia, John C. Reed

Blood (2008) 111 (6): 3211–3219.

https://doi.org/10.1182/blood-2007-09-113647

Published: 2008

Includes: Supplemental data

Journal Articles

Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma

Frederic Luciano, Maryla Krajewska, Paulina Ortiz-Rubio, Stan Krajewski, Dayong Zhai, Benjamin Faustin, Jean-Marie Bruey, Beatrice Bailly-Maitre, Alan Lichtenstein, Siva Kumar Kolluri, Arnold C. Satterthwait, Xiao-Kun Zhang, John C. Reed

Blood (2007) 109 (9): 3849–3855.

https://doi.org/10.1182/blood-2006-11-056879

Published: 2007

Includes: Supplemental data

Journal Articles

Ubiquitin-Conjugating Enzyme Ubc13 Is a Critical Component of TRAF-Mediated Inflammatory Responses.

Toru Fukushima, MD, PhD, Shu-ichi Matsuzawa, Ph.D., Christinia L. Kress, Jean Marie Bruey, Ph.D., Maryla Krajewska, M.D., Sophie Lefebvre, Ph.D., Juan M. Zapata, Ph.D., Ze’ev Ronai, Ph.D., John C. Reed, MD, Ph.D.

Blood (2006) 108 (11): 1136.

https://doi.org/10.1182/blood.V108.11.1136.1136

Published: 2006

Journal Articles

Triterpenoids Display Single Agent Activity in a Mouse Model of CLL/SBL.

Christina L. Kress, BS, Marina Konopleva, Ph.D., Maryla Krajewska, M.D., Vanesa Martinez-Garcia, B.S., Sophie Lefebvre, Ph.D., Marc L. Hyer, Ph.D., Teresa McQueen, B.S., Michael Andreeff, Ph.D., John C. Reed, MD,Ph.D, Juan Zapata, Ph.D.

Blood (2006) 108 (11): 2530.

https://doi.org/10.1182/blood.V108.11.2530.2530

Published: 2006

Journal Articles

Orphan Nuclear Receptor TR3 (Nur77) Binds and Converts the Phenotype of Bcl-B, an Anti-Apoptotic Bcl-2-Family Protein Predominantly Expressed in Human Plasma Cells.

Frederic Luciano, PhD, Maryla Krajewska, M.D., Xiaokun Zhang, Ph.D., Arnold Satterthwait, Ph.D., John C. Reed, MD, Ph.D.

Blood (2006) 108 (11): 82.

https://doi.org/10.1182/blood.V108.11.82.82

Published: 2006

Journal Articles

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Jane N. Winter, Edie A. Weller, Sandra J. Horning, Maryla Krajewska, Daina Variakojis, Thomas M. Habermann, Richard I. Fisher, Paul J. Kurtin, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, John C. Reed, Randy D. Gascoyne

Blood (2006) 107 (11): 4207–4213.

https://doi.org/10.1182/blood-2005-10-4222

Published: 2006

Journal Articles

CDDO and CDDO-Im Reduce Tumor Burden in a Transgenic Mouse Model of CLL.

Juan M. Zapata, Ph.D., Christina L. Kress, BS, Marina Konopleva, Ph.D., Maryla Krajewska, M.D., Ph.D., Mark Hyer, Ph.D., Teresa McQueen, BS, Michael Andreeff, M.D., Ph.D.

Blood (2004) 104 (11): 3477.

https://doi.org/10.1182/blood.V104.11.3477.3477

Published: 2004

Journal Articles

Prognostic Significance of Bax Protein Expression in Diffuse Aggressive Non-Hodgkin's Lymphoma

Randy D. Gascoyne, Maryla Krajewska, Stanislaw Krajewski, Joseph M. Connors, John C. Reed

Blood (1997) 90 (8): 3173–3178.

https://doi.org/10.1182/blood.V90.8.3173

Published: 1997

Journal Articles

Immunohistochemical Analysis of Interleukin-1β–Converting Enzyme/Ced-3 Family Protease, CPP32/Yama/Caspase-3, in Hodgkin's Disease

Mukesh Chhanabhai, Stanislaw Krajewski, Maryla Krajewska, Hong-Gang Wang, John C. Reed, Randy D. Gascoyne

Blood (1997) 90 (6): 2451–2455.

https://doi.org/10.1182/blood.V90.6.2451

Published: 1997

Journal Articles

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

Randy D. Gascoyne, Sheryle A. Adomat, Stanislaw Krajewski, Maryla Krajewska, Douglas E. Horsman, Anthony W. Tolcher, Susan E. O'Reilly, Paul Hoskins, Andrew J. Coldman, John C. Reed, Joseph M. Connors

Blood (1997) 90 (1): 244–251.

https://doi.org/10.1182/blood.V90.1.244

Published: 1997

Journal Articles

Immunolocalization of the ICE/Ced-3–Family Protease, CPP32 (Caspase-3), in Non-Hodgkin's Lymphomas, Chronic Lymphocytic Leukemias, and Reactive Lymph Nodes

Stanislaw Krajewski, Randy D. Gascoyne, Juan M. Zapata, Maryla Krajewska, Shinichi Kitada, Mukesh Chhanabhai, Douglas Horsman, Ken Berean, Lawrence D. Piro, Isabelle Fugier-Vivier, Yong-Jun Liu, Hong-Gang Wang, John C. Reed

Blood (1997) 89 (10): 3817–3825.

https://doi.org/10.1182/blood.V89.10.3817

Published: 1997

NARROW

Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study

Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer

Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2–transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)

Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma

Ubiquitin-Conjugating Enzyme Ubc13 Is a Critical Component of TRAF-Mediated Inflammatory Responses.

Triterpenoids Display Single Agent Activity in a Mouse Model of CLL/SBL.

Orphan Nuclear Receptor TR3 (Nur77) Binds and Converts the Phenotype of Bcl-B, an Anti-Apoptotic Bcl-2-Family Protein Predominantly Expressed in Human Plasma Cells.

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

CDDO and CDDO-Im Reduce Tumor Burden in a Transgenic Mouse Model of CLL.

Prognostic Significance of Bax Protein Expression in Diffuse Aggressive Non-Hodgkin's Lymphoma

Immunohistochemical Analysis of Interleukin-1β–Converting Enzyme/Ced-3 Family Protease, CPP32/Yama/Caspase-3, in Hodgkin's Disease

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

Immunolocalization of the ICE/Ced-3–Family Protease, CPP32 (Caspase-3), in Non-Hodgkin's Lymphomas, Chronic Lymphocytic Leukemias, and Reactive Lymph Nodes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only